The largest database of trusted experimental protocols

α mem medium

Manufactured by Cytiva
Sourced in United States

α-MEM medium is a cell culture medium formulated to support the growth and maintenance of a variety of mammalian cell lines. It provides essential nutrients and components required for cell proliferation and survival.

Automatically generated - may contain errors

2 protocols using α mem medium

1

Synovial Fibroblasts in Osteoarthritis

Check if the same lab product or an alternative is used in the 5 most similar protocols
The study was designed according to the Declaration of Helsinki, and was approved by Ethic Committee of the Second Affiliated Hospital of Harbin Medical University (KY 2021-256). Informed consent was obtained from each donor. Synovium of 3 OA patients (age 54–70 years, Kellgren-Lawrence grade 4) that underwent total joint arthroplasty (TKA) and 3 patients (age 56–68 years) that underwent meniscectomy without OA were obtained at the time after surgery. All patients were confirmed without Rheumatoid Arthritis, acute trauma, tumor or infection of knee joint. Briefly, synovium was cut into pieces at the final size about 0.5 mm*0.5 mm, and put into 0.1% type I collagenase (Biosharp, China, BS163). α-MEM medium (Cytiva, United States, SH30265.01) was added with 10% foetal bovine serum (ExCell Bio, China, FSD500) after 2 h. Primary cells could be seen climbing out after about 3–5 days. FLS of passage 6-8 (P6-8) were used in this study. 10 ng/ml of IL-1β (PEPROTECH, United States, 200-01B) were used to stimulate FLS of OA groups for 48 h in order to imitate the environment of OA, while complete medium was added into the FLS of control group. 10 μg/ml of Etanercept and Iguratimod (MedChem Express, China, HY-108847, HY-17009) were added along with IL-1β to FLS for the following test.
+ Open protocol
+ Expand
2

Isolation and Culture of Primary Chondrocytes

Check if the same lab product or an alternative is used in the 5 most similar protocols
The study was designed according to the Declaration of Helsinki and was approved by Ethic Committee of the Second Affiliated Hospital of Harbin Medical University (Ref: KY 2021-256). Written informed consent was obtained for 5 patients aging from 60 to 65 years old with OA, without rheumatoid arthritis, acute trauma, tumor, or infection of knee joint. The diagnosis of OA was based on clinical and radiological evidence of degenerative changes during surgery. The discarded specimens after total knee arthroplasty (TKA) were transferred into the biosafety cabinet within half an hour and washed twice with phosphate-buffered saline (PBS) solution to remove the blood, fat, and synovial fluid. The exposed cartilage tissue was cut into the final size about 0.5 mm × 0.5 mm, and put into 0.2% type II collagenase (Biosharp, China, BS163). After 4 hours, α-MEM medium (Cytiva, USA, SH30265.01) was added, with 10% fetal bovine serum (ExCell Bio, China, FSD500), 1% penicillin, and 1% streptomycin (Beyotime, China, C0222). Primary chondrocytes could be seen climbing out after about 7 days under optical microscope (ZEISS Axio Vert.A1, Germany). The medium was changed every 2 days and digested when the chondrocytes climbed to about 60% of the bottom. Chondrocytes used in this study were from passage 2 to 3 (P2-3).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!